Document:

Non-Employee Directors' Stock Option Plan

  
 EXHIBIT 10.67 
  
  
  
 CV Therapeutics, Inc. 
  
 NON-EMPLOYEE DIRECTORS’ STOCK OPTION PLAN 
  
 Amended and Restated by the Board of Directors on September 23, 1996 
 Approved by the Stockholders on October 29, 1996 

Amended by the Board of Directors on February 23, 2000 
 Approved by the
Stockholders on May 16, 2000 
 Amended and Restated by the Board of Directors on August 21, 2000 
 Amended and Restated by the Board of Directors on February 25, 2002 
 Amended and Restated by the Board
of Directors on April 15, 2002 
 Approved by the Stockholders on June 7, 2002 
 Amended and Restated by the Board of Directors on July 19, 2002 
  
 1.    Purpose.

  
 (a)    The purpose of the Non-Employee Directors’ Stock Option Plan (the
“Plan”) is to provide a means by which each director of CV Therapeutics, Inc. (the “Company”) who is not otherwise an employee of the Company or of any Affiliate of the Company (each such person being hereafter referred to as a
“Non-Employee Director”) will be given an opportunity to purchase stock of the Company. 
  
 (b)    The word “Affiliate” as used in the Plan means any parent corporation or subsidiary corporation of the Company as those terms are defined in Sections 424(e) and (f), respectively, of the
Internal Revenue Code of 1986, as amended from time to time (the “Code”). 
  
 (c)    The Company, by means of the Plan, seeks to retain the services of persons now serving as Non-Employee Directors of the Company, to secure and retain the services of persons capable of serving in
such capacity, and to provide incentives for such persons to exert maximum efforts for the success of the Company. 

 
 1 

  
 2.    Administration. 
  

(a)    The Plan shall be administered by the Board of Directors of the Company (the “Board”) unless and until the Board delegates
administration to a committee, as provided in subparagraph 2(b). 
  
 (b)    The Board may
delegate administration of the Plan to a committee composed of not fewer than two (2) members of the Board (the “Committee”). If administration is delegated to a Committee, the Committee shall have, in connection with the administration of
the Plan, the powers theretofore possessed by the Board, subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may abolish the Committee at any time and
revest in the Board the administration of the Plan. 
  
 3.    Shares Subject To The Plan. 

 
 (a)    Subject to the provisions of paragraph 10 relating to adjustments upon changes in stock, the
stock that may be sold pursuant to options granted under the Plan shall not exceed in the aggregate five hundred fifty thousand (550,000) shares of the Company’s common stock. If any option granted under the Plan shall for any reason expire or
otherwise terminate without having been exercised in full, the stock not purchased under such option shall again become available for the Plan. 
  
 (b)    The stock subject to the Plan may be unissued shares or reacquired shares, bought on the market or otherwise. 
  

4.    Eligibility. 
  
 Options
shall be granted only to Non-Employee Directors of the Company. 

 
 2 

  
 5.    Non-Discretionary Grants. 
  
 (a)    Each person who is a Non-Employee Director on September 23, 1996 automatically shall be granted an
option to purchase fifteen thousand (15,000) shares of the Company’s common stock (after taking into account the 1:10 reverse split adopted by the Board in September 1996) on the terms and conditions set forth herein. 
  
 (b)    Each person who is, after August 21, 2000, elected for the first time to be a Non-Employee Director
automatically shall, upon the date of such person’s initial election to be a Non-Employee Director by the Board or stockholders of the Company, be granted an option to purchase twenty-five thousand (25,000) shares of the Company’s common
stock on the terms and conditions set forth herein. 
  
 (c)    At each annual meeting of
the stockholders following the effectiveness of the initial public offering of the Company’s common stock until and including the 1998 Annual Meeting, each person then serving as a Non-Employee Director automatically shall be granted an option
to purchase five thousand (5,000) shares of the Company’s common stock (after taking into account the 1:10 reverse split adopted by the Board in September 1996) on the terms and conditions set forth herein; at each annual meeting of the
stockholders beginning with the 1999 Annual Meeting, each person then serving as a Non-Employee Director automatically shall be granted an option to purchase seven thousand five hundred (7,500) shares of the Company’s common stock on the terms
and conditions set forth herein. 
  
 6.    Option Provisions. 
  
 Each option shall be subject to the following terms and conditions: 
  
 (a)    The term of each option commences on the date it is granted and, unless sooner terminated as set forth herein, expires on the date
(“Expiration Date”) ten (10) years from the date of grant. If the optionee’s service as a Director of the Company terminates for any reason or for no reason, the option shall terminate on the earlier of the Expiration Date or the date
three 

 
 3 

 
(3) months following the date of termination of service; provided, however, that if such termination of service is due to the optionee’s death, the option shall terminate on the
earlier of the Expiration Date or eighteen (18) months following the date of the optionee’s death. In any and all circumstances, an option may be exercised following termination of the optionee’s service as a Non-Employee Director of the
Company only as to that number of shares as to which it was exercisable on the date of termination of such service under the provisions of subparagraph 6(e). 
  
 (b)    Subject to applicable law, the exercise price of each option shall be the fair market value of the stock subject to such option on the date such option is granted.

  
 (c)    The optionee may elect to make payment of the exercise price under one of the
following alternatives: 
  
 (i)    Payment of the exercise price per share in cash at the
time of exercise; or 
  
 (ii)    Provided that at the time of the exercise the
Company’s common stock is publicly traded and quoted regularly in the Wall Street Journal, payment by delivery of shares of common stock of the Company already owned by the optionee, held for the period required to avoid a charge to the
Company’s reported earnings, and owned free and clear of any liens, claims, encumbrances or security interest, which common stock shall be valued at its fair market value on the date preceding the date of exercise; or 
  
 (iii)    Payment by a combination of the methods of payment specified in subparagraph 6(c)(i) and 6(c)(ii)
above. 
  
 Notwithstanding the foregoing, this option may be exercised pursuant to a program developed under
Regulation T as promulgated by the Federal Reserve Board which results in the receipt of cash (or check) by the Company prior to the issuance of shares of the Company’s common stock. 

 
 4 

  
 (d)    An option shall by its terms be personal and
may not be sold, pledged, assigned, transferred, encumbered or otherwise alienated or hypothecated in any manner other than by will or the laws of descent and distribution or to a Permitted Transferee (as defined below) or by a Permitted Transferee
to a Family Member (as defined below). During the lifetime of an optionee, only he or she or a Permitted Transferee may exercise an option, or any portion thereof, granted to the optionee under the Plan. 
  
 (i)    An option transferred to a Permitted Transferee shall not be assignable or transferable by the Permitted
Transferee to any person or entity, other than the original optionee’s Family Members. 
  
 (ii)    Any option which is transferred to a Permitted Transferee shall continue to be subject to all the terms and conditions of the option as applicable to the original optionee. 
  
 (iii)    The optionee and the Permitted Transferee shall execute any and all documents reasonably requested by
the Company, including without limitation documents to (A) confirm the status of the transferee as a Permitted Transferee, (B) satisfy any requirements for an exemption for the transfer under applicable federal and state securities laws and (C)
evidence the transfer. In the event any option is exercised by, or to be paid to, the executors, administrators, heirs or distributees of the estate of a deceased optionee, or such an optionee’s beneficiary, or the transferee of an option, in
any such case pursuant to the terms and conditions of the Plan, the Company shall be under no obligation to issue stock, or make any payment, thereunder unless and until the Company is satisfied that the person or persons exercising such option, or
to receive such payment, is the duly appointed legal representative of the deceased optionee’s estate or the proper legatee or distributee thereof or the named beneficiary of such optionee, or the Permitted Transferee of such option, as
applicable. 

 
 5 

  
 (iv)    Shares of stock acquired by a Permitted
Transferee through exercise of an option may not be transferred, nor will any assignee or transferee thereof be recognized as an owner of such shares of common stock for any purpose, unless a registration statement under the Securities Act of 1933,
as amended, and any applicable state securities act with respect to such shares shall then be in effect or unless the availability of an exemption from registration with respect to any proposed transfer or disposition of such shares shall be
established to the satisfaction of counsel for the Company. 
  
 (v)    For purposes of
this Plan, the following terms shall have the following meanings: 
  
 A.    “Permitted
Transferee” shall mean a Family Member who receives an option from an optionee as a gift not for value or a person or entity to whom an option is transferred by an optionee in a Permitted Transfer for Value. 
  
 B.    “Permitted Transfer for Value” shall mean any transfer of an option (i) under a domestic relations
order in a settlement of marital property rights, or (ii) to an entity in which more than fifty percent (50%) of the voting interests are owned by Family Members (or the optionee) in exchange for an interest in that entity. 
  
 C.    “Family Member” shall mean an optionee’s child, stepchild, grandchild, parent, stepparent,
grandparent, spouse, former spouse, sibling, niece, nephew, mother in law, father in law, son in law, daughter in law, brother in law or sister in law, including adoptive relationships, any person sharing the optionee’s household (other than a
tenant or employee), a trust in which these persons have more than fifty percent of the beneficial interest, a foundation in which these persons (or the optionee) control the management of assets, and any other entity in which these persons (or the
optionee) own more than fifty percent (50%) of the voting interest. 

 
 6 

  
 (e)    Each option shall become exercisable as
follows: the initial grants described in Sections 5(a) and 5(b) shall become exercisable (“vest”) at the rate of two and seventy-seven one hundredths percent (2.77%) per month over the thirty-six (36) months after the date of grant; and
the annual grants described in Section 5(c) shall vest at the rate of eight and thirty-three one hundredths (8.33%) per month over the twelve-month (12-month) period following the date of grant; provided that the optionee has, during the entire
period prior to such vesting date, continuously served as a Non-Employee Director or as an employee of or consultant to the Company or any Affiliate of the Company, whereupon such option shall become fully exercisable in accordance with its terms
with respect to that portion of the shares represented by that installment. 
  
 (f)    The
Company may require any optionee, or any person to whom an option is transferred under subparagraph 6(d), as a condition of exercising any such option: (i) to give written assurances satisfactory to the Company as to the optionee’s knowledge
and experience in financial and business matters; and (ii) to give written assurances satisfactory to the Company stating that such person is acquiring the stock subject to the option for such person’s own account and not with any present
intention of selling or otherwise distributing the stock. These requirements, and any assurances given pursuant to such requirements, shall be inoperative if (i) the issuance of the shares upon the exercise of the option has been registered under a
then-currently-effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”), or (ii), as to any particular requirement, a determination is made by counsel for the Company that such requirement need
not be met in the circumstances under the then-applicable securities laws. 
  
 (g)    Notwithstanding anything to the contrary contained herein, an option may not be exercised unless the shares issuable upon exercise of such option are then registered under the 

 
 7 

 
Securities Act or, if such shares are not then so registered, the Company has determined that such exercise and issuance would be exempt from the registration requirements of the Securities Act.

  
 (h)    The Company (or a representative of the underwriters) may, in connection with
the first underwritten registration of the offering of any securities of the Company under the Securities Act, require that any optionee not sell or otherwise transfer or dispose of any shares of common stock or other securities of the Company
during such period (not to exceed one hundred eighty (180) days) following the effective date of the registration statement of the Company filed under the Securities Act as may be requested by the Company or the representative of the underwriters.

  
 7.    Covenants Of The Company. 
  
 (a)    During the terms of the options granted under the Plan, the Company shall keep available at all times the number of shares of stock
required to satisfy such options. 
  
 (b)    The Company shall seek to obtain from each
regulatory commission or agency having jurisdiction over the Plan such authority as may be required to issue and sell shares of stock upon exercise of the options granted under the Plan; provided, however, that this undertaking shall not
require the Company to register under the Securities Act either the Plan, any option granted under the Plan, or any stock issued or issuable pursuant to any such option. If, after reasonable efforts, the Company is unable to obtain from any such
regulatory commission or agency the authority which counsel for the Company deems necessary for the lawful issuance and sale of stock under the Plan, the Company shall be relieved from any liability for failure to issue and sell stock upon exercise
of such options. 
  
 8.    Use Of Proceeds From Stock. 
  
 Proceeds from the sale of stock pursuant to options granted under the Plan shall constitute general funds of the Company. 

 
 8 

  
 9.    Miscellaneous. 
  

(a)    Neither an optionee nor any person to whom an option is transferred under subparagraph 6(d) shall be deemed to be the holder of, or
to have any of the rights of a holder with respect to, any shares subject to such option unless and until such person has satisfied all requirements for exercise of the option pursuant to its terms. 
  
 (b)    Nothing in the Plan or in any instrument executed pursuant thereto shall confer upon any Non-Employee
Director any right to continue in the service of the Company or any Affiliate or shall affect any right of the Company, its Board or stockholders or any Affiliate to terminate the service of any Non-Employee Director with or without cause.

  
 (c)    No Non-Employee Director, individually or as a member of a group, and no
beneficiary or other person claiming under or through him, shall have any right, title or interest in or to any option reserved for the purposes of the Plan except as to such shares of common stock, if any, as shall have been reserved for him
pursuant to an option granted to him. 
  
 (d)    In connection with each option made
pursuant to the Plan, it shall be a condition precedent to the Company’s obligation to issue or transfer shares to a Non-Employee Director, or to evidence the removal of any restrictions on transfer, that such Non-Employee Director make
arrangements satisfactory to the Company to insure that the amount of any federal or other withholding tax required to be withheld with respect to such sale or transfer, or such removal or lapse, is made available to the Company for timely payment
of such tax. 
  
 (e)    As used in this Plan, fair market value means, as of any date, the
value of the common stock of the Company determined as follows: 
  
 (i)    If the common
stock of the Company is listed on any established stock exchange, or traded on the Nasdaq National Market or the Nasdaq SmallCap Market, the fair market value of a share of common stock of the Company shall be the closing sales price for
 

 
 9 

 
such stock (or the closing bid, if no sales were reported) as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in common stock of the Company) on
the last market trading day prior to the day of determination, as reported in the Wall Street Journal or such other source as the Board deems reliable; 
  
 (ii)    In the absence of such markets for the common stock of the Company, the fair market value shall be determined in good faith by the Board. 
  
 10.    Adjustments Upon Changes In Stock. 
  
 (a)    If any change is made in the stock subject to the Plan, or subject to any option granted under the Plan (through merger, consolidation, reorganization,
recapitalization, stock dividend, dividend in property other than cash, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or otherwise), the Plan and outstanding options will be appropriately
adjusted in the class(es) and maximum number of shares subject to the Plan and the class(es) and number of shares and price per share of stock subject to outstanding options. 
  
 (b)    In the event of: (1) a merger or consolidation in which the Company is not the surviving corporation; (2) a reverse merger in which the
Company is the surviving corporation but the shares of the Company’s common stock outstanding immediately preceding the merger are converted by virtue of the merger into other property, whether in the form of securities, cash or otherwise; or
(3) any other capital reorganization in which more than fifty percent (50%) of the shares of the Company entitled to vote are exchanged, any surviving corporation, other than the Company, shall assume any options outstanding under the Plan or shall
substitute similar options for those outstanding under the Plan or, if the Company is the surviving corporation, such options shall continue in full force and effect. 

 
 10 

  
 11.    Amendment Of The Plan And Options. 
  
 (a)    The Board at any time, and from time to time, may amend the Plan. Except as provided in paragraph 10
relating to adjustments upon changes in stock, no amendment shall be effective unless approved by the stockholders of the Company within twelve (12) months before or after the adoption of the amendment, where the amendment will increase the number
of shares which may be issued under the Plan. 
  
 (b)    The Board at any time, and from
time to time, may amend the terms of any one or more options granted under the Plan; provided, however, that the rights and obligations under any option granted before any amendment of the Plan shall not be altered or impaired by such amendment
unless (i) the Company requests the consent of the person to whom the option was granted and (ii) such person consents in writing. Notwithstanding the foregoing, the Board shall not, without the approval of the stockholders of the Company, authorize
the amendment of any outstanding option to reduce its exercise price. Furthermore, no option shall be canceled and replaced with grants having a lower exercise price without the further approval of stockholders of the Company. 

 
 12.    Termination Or Suspension Of The Plan. 
  
 (a)    The Board may suspend or terminate the Plan at any time. Unless sooner terminated, the Plan shall terminate on September 23, 2006. No
options may be granted under the Plan while the Plan is suspended or after it is terminated. 
  
 (b)    Rights and obligations under any option granted while the Plan is in effect shall not be altered or impaired by suspension or termination of the Plan, except with the consent of the person to whom
the option was granted. 
  
 (c)    The Plan shall terminate upon the occurrence of any of
the events described in Section 10(b) above. 

 
 11 

  
 13.    Effective Date Of Plan; Conditions Of Exercise. 

 
 (a)    This amendment and restatement of the Plan shall become effective upon adoption by the Board
of Directors, subject to the condition subsequent that this amendment and restatement of the Plan is approved by the stockholders of the Company. Following the effective date of this amendment and restatement, options shall not be granted under the
terms of the Plan in effect prior to such effective date. 
  
 (b)    No option granted
under the Plan shall be exercised or exercisable unless and until the condition of subparagraph 13(a) above has been met. 

 
 12Addendum to Offer Letter, dated June 12,2002

 EXHIBIT 10.53 
  
  
 June 12, 2002 
  
 Jow H. Peng 
 44477 Parkmeadow Drive 
 Fremont, CA 94539 
  
 Re:  Addendum to Offer Letter 
  
 Dear Jow, 
  

This letter acts as an addendum (the “Addendum”) to the offer letter dated August 18, 1997 (the “Offer Letter”) between you and
Integrated Telecom Express, Inc. (the “Company”). This Addendum amends the Offer Letter and supersedes all provisions related to severance and target bonus payments, effective September 6, 2002 (the “Effective
Date”). All other provisions of the Offer Letter shall remain in full force and effect. 
  
 In consideration
for your continued employment with the Company and to assist in its liquidation process (the “Liquidation”), you shall be entitled to the following: 
  
 Upon the date that shareholders approve the Liquidation of the Company, your outstanding options to purchase common stock of the Company (the “Options”)
shall immediately vest and become exercisable as to 100% of the shares subject to such Options. Thereafter, the Options shall continue to be bound by and subject to the option plan and option agreements under which they were granted. 

 
 As of the Effective Date, you have earned $25,000 of your target performance bonus of $50,000. The Company shall pay you such
earned bonus, less applicable withholding, on the first regular payroll date following the Effective Date. Following the Effective Date, upon completion of each applicable Liquidation Task (as defined below) prior to your termination of employment,
the Company shall, on the first regular payroll date following the completion of such Liquidation Task, pay you a portion of the remaining target performance bonus in a lump-sum payment equal to the amount described below. A “Liquidation
Task” shall mean one of the following tasks, each of which the Company believes is critical to the consummation of the Liquidation (collectively, the “Liquidation Tasks”): 
  
 (i)  Mailing of Proxy.    On the date the Company mails to its stockholders the proxy statement for
the special meeting of stockholders at which the Company’s stockholders will consider a proposal to approve the Liquidation, the Company shall pay $2,500, less applicable withholding taxes (with payment due on the first regular payroll date
following the completion of this Liquidation Task). 

  
 (ii)  Filing of Certificate of
Dissolution.    On the date the Company files the certificate of dissolution following the date the Company’s stockholders approve the Liquidation, the Company shall pay you $2,500, less applicable withholding taxes
(with payment due on the first regular payroll date following the completion of this Liquidation Task). 
  
  
 (iii)  Completion of Plan for Liquidation.    On the date of completion of a plan outlining in reasonable detail the essential elements and tasks intended to
establish that the Company and the Board have acted in due care in consummating the Liquidation, the Company shall pay you $6,250, less applicable withholding (with payment due on the first regular payroll date following the completion of this
Liquidation Task). 
  
 (iv)  Resolution of Leaseholds.    On the date the
Company reaches a final written agreement with the landlord for its facilities at 400 Race Street, San Jose, California with respect to the Company’s obligations under the lease for such facility, the Company shall pay you $2,500, less
applicable withholding (with payment due on the first regular payroll date following the completion of this Liquidation Task). 
  
 (v)   Employee Terminations.    On the date the Company completes the final termination of Company employees, other than those employees necessary to assist in the consummation of the
Liquidation as determined in good faith by Jim Regel and Jim Williams, the Company shall pay you $2,500, less applicable withholding (with payment due on the first regular payroll date following the completion of this Liquidation Task).

  
 (vi)  Initial Distribution.    On the date the Company makes its initial
distribution of assets to the Company’s stockholders in connection with the Liquidation (the “Initial Distribution”), the Company shall pay you $6,250, less applicable withholding (with payment due on the first regular payroll
date following the completion of this Liquidation Task). 
  
 (vii)  Final Tax
Filings.    On the date the Company has provided to its independent accountants all information reasonably requested by such accountants in connection with the preparation of the Company’s corporate tax returns and any
other tax related filings for the tax year in which the Initial Distribution occurs, the Company shall pay you $2,500, less applicable withholding (with payment due on the first regular payroll date following the completion of this Liquidation
Task). The Company shall use its reasonable efforts to cause its independent accountants to deliver a request for information as soon as practicable after the Effective Date. After such information has been provided, the Company shall in writing
make a final inquiry of its independent accountants regarding their need for additional information. If the independent accountants confirm that they have received all reasonably requested information (or fail to respond to such inquiry within
twenty (20) calendar days), then this Liquidation Task shall be deemed completed. If the independent accountants reasonably request additional information, then this Liquidation Task shall be deemed completed upon delivery of such additional
information. 
  
 In addition, if your employment with the Company is involuntarily terminated for other than for
“Cause” (as defined below), and you sign and do not revoke a standard release of claims with the Company, then, you shall be entitled to (i) receive a lump-sum severance payment (less applicable withholding taxes) equal to your base salary
rate, as then in effect, for a period of twelve (12) 

  
 months to be paid in a lump sum within thirty (30) days of the date of your termination, (ii) payment of
the unearned portion of the remaining target performance bonus, if any, as if the Liquidation Tasks had been completed in full, and (iii) reimbursement by the Company of the group health continuation coverage premiums for you and your eligible
dependents under Title X of the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”) as in effect through the lesser of (x) twelve (12) months from the effective date of such termination, (y) the date upon which you
and your eligible dependents become covered under similar plans, or (z) the date Executive no longer constitutes a “Qualified Beneficiary” (as such term is defined in Section 4980B(g) of the Internal Revenue Code of 1986, as amended
(the “Code”)); provided, however, that you will be solely responsible for electing such coverage within the required time periods. Your voluntary resignation following the completion of all of the Liquidation Tasks set forth above
will be considered a termination without Cause for purposes of this severance provision, and you will be entitled to the severance benefits set forth in this paragraph. 
  
 For purposes of this Addendum, “Cause” is defined as (i) an act of dishonesty made by you in connection with your responsibilities as an employee, (ii)
your conviction of, or plea of nolo contendere to, a felony, (iii) your gross misconduct, or (iv) your continued substantial violations of his employment duties after you have received a written demand for performance from the Company which
specifically sets forth the factual basis for the Company’s belief that you have not substantially performed your duties. 
  
 In the event of any dispute or claim relating to or arising out of your employment relationship with the Company, you and the Company agree that (i) any and all disputes between you and the Company shall be fully and finally resolved
by binding arbitration, (ii) you are waiving any and all rights to a jury trial but all court remedies will be available in arbitration, (iii) all disputes shall be resolved by a neutral arbitrator who shall issue a written opinion, (iv) the
arbitration shall provide for adequate discovery, and (v) the Company shall pay all arbitration fees.  
  
 By
countersigning this letter, you confirm that this Addendum supersedes the provisions in your Offer Letter, and any other understandings, whether written or oral, relating to severance benefits and the payment of any target bonuses. In the event of
any inconsistencies between the Offer Letter and this Addendum, this Addendum will control. 
  
 You also acknowledge
that you have had the opportunity to discuss this matter with and obtain advice from your private attorney, have had sufficient time to, and have carefully read and fully understand all the provisions of this Addendum and your Offer Letter, and are
knowingly and voluntarily entering into this Addendum. 
  
 This Addendum to your Offer Letter does not alter the
nature of your employment with the Company, and your employment remains “at will” and is of no specific duration. 

  
 If you have any questions concerning this offer, please contact me immediately at
(408) 513-9207. If you accept our offer, please sign this offer letter where indicated and return it to me or fax it to (408) 513-9405. This offer will expire of its own accord if it is not accepted in writing by 5pm on September 6, 2002.

  
 
	 Sincerely,
 	 	  	 	 Accepted and agreed
 
	 
	 /s/    James G. Regel
 
	 	  	 	 By:
 	 	 /s/    Jow Peng
 

	 JAMES G. REGEL
 PRESIDENT & CEO
 	 	  	 	  	 	 JOW PENG

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}]]